CD8型
MHC I级
T细胞受体
MHC限制
主要组织相容性复合体
细胞生物学
细胞毒性T细胞
上皮内淋巴细胞
生物
与抗原处理相关的转运体
抗原
T细胞
化学
分子生物学
免疫学
免疫系统
生物化学
体外
作者
Andrew J. Leishman,Olga V. Naidenko,Antoine Attinger,Frits Koning,Christopher J. Lena,Yongqiang Xiong,Huiyou Chang,Ellis L. Reinherz,Mitchell Kronenberg,Hilde Cheroutre
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:2001-11-30
卷期号:294 (5548): 1936-1939
被引量:239
标识
DOI:10.1126/science.1063564
摘要
The thymus leukemia antigen (TL) is a nonclassical class I molecule, expressed abundantly on intestinal epithelial cells. We show that, in contrast to other major histocompatibility complex (MHC) class I molecules that bind CD8αβ, TL preferentially binds the homotypic form of CD8α (CD8αα). Thus, TL tetramers react specifically to CD8αα-expressing cells, including most intestinal intraepithelial lymphocytes. Compared with CD8αβ, which recognizes the same MHC as the T cell receptor (TCR) and thus acts as a TCR coreceptor, high-affinity binding of CD8αα to TL modifies responses mediated by TCR recognition of antigen presented by distinct MHC molecules. These findings define a novel mechanism of lymphocyte regulation through CD8αα and MHC class I.
科研通智能强力驱动
Strongly Powered by AbleSci AI